Online inquiry

IVTScrip™ mRNA-Human ANGEL2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17878MR)

This product GTTS-WK17878MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANGEL2 protein. This product can be used in Ionocyte cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001300753.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 90806
UniProt ID Q5VTE6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANGEL2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17878MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK13149MR IVTScrip™ mRNA-Human ADH5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADH5
GTTS-WK2089MR IVTScrip™ mRNA-Human CYP17, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA CYP17
GTTS-WK18712MR IVTScrip™ mRNA-Human ALG12, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ALG12
GTTS-WK8912MR IVTScrip™ mRNA-Human ADAR, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAR
GTTS-WK21827MR IVTScrip™ mRNA-Human ASRGL1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASRGL1
GTTS-WK13867MR IVTScrip™ mRNA-Human ABHD17B, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ABHD17B
GTTS-WK13048MR IVTScrip™ mRNA-Human ACSL4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACSL4
GTTS-WK15392MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →